EUVIMEDEUVIMED entdecken
Klinische Studie

Effects of Diquafosol Sodium Ophthalmic Solution on Tear Film Matrix Metallopeptidase-9 and Corneal Nerve Density in Patients with Type 2 Diabetic Dry Eye

Guanghao Qin iD, Jiayan Chen, Liangzhe Li, Yifan Qi, Yimeng Chen, Qing Zhang iD, Yi Wu iD, Yue You, Lanting Yang, Naici Guo, Salissou Moutari, Shaochong Bu und 6 weitere

Journal of Ocular Pharmacology and Therapeutics · 01.08.2024 · 40 (6) · 370-378

DOI: 10.1089/jop.2023.0098 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, online erschienen am 19.08.2024. Verfasst von Guanghao Qin und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, He Eye Specialist Hospital, Shenyang, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Dry Eye Syndromes, Matrix Metalloproteinase 9, Ophthalmic Solutions. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Diabetes mellitus has been associated with increased dry eye disease (DED) and exacerbates DED's pathology. This preliminary short-term study aimed to evaluate the effects of 3% Diquafosol Sodium ophthalmic solution (DQS) on ocular surface inflammation and corneal nerve density in diabetic dry eye (DDE) patients.

Methods

In this perspective, participants used 1 drop of 3% DQS (Diquas; Santen Pharmaceutical Co., Ltd., Osaka, Japan) 6 times daily for 8 weeks. Non-invasive tear breakup time (NITBUT), tear film lipid layer (TFLL), conjunctival hyperemia [redness score (RS)], corneoconjunctival staining (CFS), corneal sensitivity (CS), Meibomian gland quality (MGQ) and Meibomian gland expressibility (MGEx), corneal nerve fiber density (CNFD), and Standard Patient Evaluation Eye Dryness (SPEED) questionnaire were assessed at baseline, at weeks 4, and up to 8 weeks. Matrix metalloproteinase-9 (MMP-9) of tear samples was measured at baseline and weeks 8.

Results

The mean age was 61.27 ± 11.68 years. At baseline NITBUT = 5.89 ± 2.81 s, tear meniscus height = 0.17 ± 0.05 mm, TFLL = 2.74 ± 0.51, CFS = 4.35 ± 0.68, CS = 53.83 ± 9.63 mm, MMP-9 = 49.10 ± 10.42 ng/mL, RS = 1.65 ± 0.44, MGEx = 1.85 ± 0.72, MGQ = 2.65 ± 0.50, CNFD = 20.36 ± 8.20 no./mm 2 , and SPEED = 12.62 ± 3.91. At week 4, significant improvements were found in all parameters except RS (1.59 ± 0.46, P = 0.172) and CNFD (21.46 ± 8.41, P = 0.163). Finally, at week 8, all parameters had significant improvements.

Conclusion

Preliminary short-term findings suggest that treatment of DDE patients with DQS was found to be safe and efficacious in improving dry eye parameters. In addition, inflammatory marker and corneal nerve density were significantly improved. This study was registered with ClinicalTrials.gov (NCT05193331).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Dry Eye SyndromesMatrix Metalloproteinase 9Ophthalmic SolutionsPolyphosphatesTearsUracil NucleotidesAgedFemaleHumansMaleMiddle AgedCornea

Stichwörter der Autor:innen

MMP-9SPEEDcorneal nervediabetesdiquafosoldry eye diseaseinflammationtear film

Substanzen

diquafosolMatrix Metalloproteinase 9MMP9 protein, humanOphthalmic SolutionsPolyphosphatesUracil Nucleotides

Autor:innen und Institutionen

  • Department of Ophthalmology, He Eye Specialist Hospital, Shenyang, China.
  • Department of Ophthalmology, Jinzhou Medical University, Jinzhou, China.
  • Department of Ophthalmology, Tianjin Medical University, Tianjin, China.
  • Department of Ophthalmology, China Medical University, Shenyang, China.
  • Department of Ophthalmology, Sinqi Eye Hospital, Shenyang, China.
  • Department of Ophthalmology, Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Guanghao Qin, Qing Zhang, Yi Wu

Zitieren

APA

Qin, G., Chen, J., Li, L., Qi, Y., Chen, Y., Zhang, Q., Wu, Y., You, Y., Yang, L., Guo, N., Moutari, S., Bu, S., Moore, J. E., Xu, L., He, W., Yu, S., He, X., & Pazo, E. E. (2024). Effects of Diquafosol Sodium Ophthalmic Solution on Tear Film Matrix Metallopeptidase-9 and Corneal Nerve Density in Patients with Type 2 Diabetic Dry Eye. Journal of Ocular Pharmacology and Therapeutics, 40(6), 370-378. https://doi.org/10.1089/jop.2023.0098

Vancouver

Qin G, Chen J, Li L, Qi Y, Chen Y, Zhang Q, et al. Effects of Diquafosol Sodium Ophthalmic Solution on Tear Film Matrix Metallopeptidase-9 and Corneal Nerve Density in Patients with Type 2 Diabetic Dry Eye. Journal of Ocular Pharmacology and Therapeutics. 2024;40(6):370-378. doi:10.1089/jop.2023.0098

BibTeX
@article{Qin2024,
  author = {Qin, Guanghao and Chen, Jiayan and Li, Liangzhe and Qi, Yifan and Chen, Yimeng and Zhang, Qing and Wu, Yi and You, Yue and Yang, Lanting and Guo, Naici and Moutari, Salissou and Bu, Shaochong and Moore, Jonathan E and Xu, Ling and He, Wei and Yu, Sile and He, Xingru and Pazo, Emmanuel Eric},
  title = {Effects of Diquafosol Sodium Ophthalmic Solution on Tear Film Matrix Metallopeptidase-9 and Corneal Nerve Density in Patients with Type 2 Diabetic Dry Eye},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2024},
  volume = {40},
  number = {6},
  pages = {370--378},
  doi = {10.1089/jop.2023.0098}
}
Kostenlos starten →